Ropinirole Extended Release (XR)

DRUG3 trials

Sponsors

GlaxoSmithKline

Conditions

Restless Legs SyndromeRestless Legs Syndrome (RLS)

Phase 3

Ropinirole XR (Extended Release) In Patients With Restless Legs Syndrome

CompletedNCT00197080

GlaxoSmithKlineRestless Legs Syndrome

Start: 2005-06-30End: 2006-01-31Target: 380Updated: 2016-09-23

RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole

CompletedNCT00314860

GlaxoSmithKlineRestless Legs Syndrome, Restless Legs Syndrome (RLS)

Start: 2006-02-28End: 2006-12-31Updated: 2016-10-18

Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome

CompletedNCT00355641

GlaxoSmithKlineRestless Legs Syndrome

Start: 2005-10-31End: 2007-10-31Updated: 2016-10-28